Home News

2018 full year results presentation

Operating income, growth figures, profitability and how our products have behaved.

Tue, 26/02/2019 - 11:15 0 min
Download related document
No votes yet
 
Related
ROVI signs a co-operation agreement for a clinical trial to study the efficacy and safety of bemiparin in patients hospitalised with pneumonia caused by COVID-19
ROVI signs a co-operation agreement for a clinical trial to study the efficacy...
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has signed a co-operation agreement with Fundación de Investigación HM Hospitales to fund a...
2 min
14/04/2020
ROVI informs on the impact of Covid 19 on the company’s activities
ROVI informs on the impact of Covid 19 on the company’s activities
Laboratorios Farmacéuticos ROVI, S.A. (ROVI) reports that, since the beginning of the spread of Covid-19, the company has been executing...
6 min
02/04/2020
ROVI will donate a million surgical masks to the Ministry of Health
ROVI will donate a million surgical masks to the Ministry of Health
Since the beginning of the health crisis caused by the expansion of COVID-19, ROVI has been taking measures to ensure the continuity of its...
1 min
26/03/2020